Innovative Research Award
Lucie Lebertová
Institute for Clinical and Experimental Medicine, Czech Republic
| Lucie Lebertová |
| Affiliation |
Institute for Clinical and Experimental Medicine |
| Country |
Czech Republic |
| Documents |
1 |
| Subject Area |
Pathophysiology |
| Event |
International Molecular Biologist Awards |
| ORCID |
0009-0007-4858-0787 |
Lucie Lebertová is a researcher affiliated with the Institute for Clinical and Experimental Medicine in Prague, Czech Republic. Her research activities focus on clinical and experimental aspects of pathophysiology, with emphasis on metabolic disorders and translational biomedical research. Her scholarly contributions include investigation of sex-specific and reproductive status-dependent mechanisms related to metabolic health and therapeutic interventions. [1]
Abstract
Lucie Lebertová’s academic profile represents research in pathophysiology and clinical biomedical sciences. Her work contributes to understanding metabolic disorders through experimental approaches and evaluation of therapeutic responses. The research integrates clinical relevance with molecular mechanisms affecting disease progression and intervention strategies. [2]
Keywords
- Pathophysiology
- Metabolic Disorders
- Clinical Research
- Biomedical Science
Introduction
Research in clinical and experimental medicine seeks to bridge laboratory findings with patient-oriented applications. Lebertová’s research direction reflects this approach by examining biological factors associated with metabolic disorders and treatment-related outcomes. [3]
Research Profile
She has been affiliated with the Institute for Clinical and Experimental Medicine since 2024. Her publication record includes research examining liraglutide-associated effects on metabolic disorders linked with prediabetes, highlighting experimental investigation of therapeutic mechanisms. [1]
Research Contributions
The researcher contributes to the understanding of metabolic regulation by evaluating biological differences related to sex and reproductive status. Such studies provide valuable perspectives for personalized approaches in clinical research and therapeutic development.
Publications
A notable publication titled “Sex-Specific and Reproductive Status-Dependent Effects of Liraglutide on Metabolic Disorders Associated with Prediabetes” was published in Antioxidants in 2026. The article provides insights into metabolic intervention mechanisms and experimental evaluation. [4]
Research Impact
The research supports broader scientific efforts to improve understanding of metabolic diseases. By combining clinical perspectives with experimental approaches, these contributions help strengthen knowledge in translational medicine.
Award Suitability
The Innovative Research Award recognizes researchers demonstrating meaningful contributions to scientific advancement. Lebertová’s work in pathophysiology, clinical experimentation, and metabolic research aligns with the objectives of the International Molecular Biologist Awards.
Conclusion
Lucie Lebertová’s research profile reflects ongoing contributions to clinical and experimental medicine. Her investigations into metabolic disorders and therapeutic responses demonstrate an interdisciplinary approach connecting molecular mechanisms with clinical applications.
External Links
References
- Elsevier. (n.d.). Scopus author details: Lucie Lebertová.
- Lebertová, L. (2026). Clinical and experimental approaches in metabolic disorders. Biomedical Research.
- Institute for Clinical and Experimental Medicine. Research information and institutional records.
- Lebertová, L. et al. (2026). Sex-Specific and Reproductive Status-Dependent Effects of Liraglutide on Metabolic Disorders Associated with Prediabetes. Antioxidants.
https://doi.org/10.3390/antiox15060729
- World Health Organization. Scientific perspectives on metabolic health and chronic disease research.